OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green bought 36,650 shares of the firm’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was acquired at an average cost of $0.57 per share, with a total value of $20,890.50. Following the transaction, the chief executive officer owned 1,896,375 shares of the company’s stock, valued at $1,080,933.75. This represents a 1.97% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Aaron Green also recently made the following trade(s):
- On Monday, June 15th, Aaron Green purchased 18,702 shares of OneMedNet stock. The stock was acquired at an average price of $0.54 per share, for a total transaction of $10,099.08.
- On Friday, June 12th, Aaron Green purchased 36,920 shares of OneMedNet stock. The stock was acquired at an average price of $0.56 per share, for a total transaction of $20,675.20.
OneMedNet Price Performance
Shares of NASDAQ:ONMD opened at $0.63 on Thursday. The company’s 50-day moving average price is $0.82 and its two-hundred day moving average price is $0.91. OneMedNet Corporation has a one year low of $0.44 and a one year high of $4.22. The stock has a market capitalization of $34.35 million, a PE ratio of -12.62 and a beta of 1.12.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. HRT Financial LP acquired a new position in shares of OneMedNet during the 4th quarter worth about $32,000. State Street Corp lifted its stake in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the last quarter. Jane Street Group LLC acquired a new stake in OneMedNet in the 4th quarter valued at about $119,000. Virtu Financial LLC bought a new position in OneMedNet during the fourth quarter worth about $48,000. Finally, Exencial Wealth Advisors LLC grew its holdings in OneMedNet by 1.3% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after purchasing an additional 45,401 shares during the period. Institutional investors own 0.95% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages recently commented on ONMD. Weiss Ratings reissued a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen cut OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Get Our Latest Research Report on ONMD
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Stories
- Five stocks we like better than OneMedNet
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
